By Martha A. Belury
ESI Special Topics,
November 2003
Citing URL - http://www.esi-topics.com/nhp/2003/november-03-MarthaABelury.html
|
Martha A. Belury answers a few questions about this month's
new hot paper in the field of Agricultural Sciences.
From
•>>November 2003
[*Late Entry]
Field:
Agricultural Sciences
Article Title: Dietary conjugated linoleic acid in health: Physiological effects and mechanisms of action
Authors: Belury, MA
Journal: ANNU REV NUTR
Volume: 22:
Page: 505-531
Year: 2002
* NW Hosp, Dept Mol Med, 21720 23rd Dr SE, Bothell, WA 98021 USA.
* NW Hosp, Dept Mol Med, Bothell, WA 98021 USA.
|
Why
do you think your paper is highly cited?
This chapter in the Annual Review of Nutrition is a broad
review of the literature about the implications of conjugated
linoleic acid (CLA) for human health. CLA seems to have such a broad
sweep of effects in terms of cancer, diabetes, obesity, and
immunity. It appears that most of the other researchers citing this
chapter are conducting research on
some aspect of CLA as it relates to one of these areas.
Does
it describe a new discovery or a new methodology that's useful to
others?
The chapter is one of the more comprehensive reviews out right
now on the literature addressing CLA. Researchers are increasingly
interested in studying CLA because of the discovery of its effects
on human health and illness as listed above—cancer, diabetes,
obesity, and immunity. In addition, CLA may be of interest because
it seems to be a fat that actually has benefits, which goes against
the misconception that all fats are bad. Since CLA is readily
available as a supplement, its potential as a safe complementary
medicine is of great interest. This matches the current societal
trend toward interest in the use of complementary and alternative
medicines to improve our health.
Could
you summarize the significance of your paper in layman's terms?
This book chapter is a review of the existing literature on CLA.
The studies highlighted address some of the human health
implications of CLA, as well as the potential mechanisms that
explain how it works at the molecular level. This type of research
helps us understand how a biochemical compound works and how much of
it is needed to cause certain effects. This understanding is the
first necessary step required in developing a safe nutritional
therapy.
How
did you become involved in this research?
In 1993, I was looking for fatty acids that had anti-cancer
effects and CLA emerged as a strong candidate for preventing mouse
skin carcinogenesis. Then I began to look at how CLA was metabolized
in the liver and found that it has powerful effects on fat and
glucose metabolism. Today, my research at Ohio State University
centers on how CLA affects conditions associated with insulin
resistance, such as gestational diabetes and type 2 diabetes. I am
hopeful that we can make a difference for people with diabetes by
developing nutritional therapies
that aid the management of
these diseases or even prevent them.
Martha A. Belury
Associate Professor, Nutritional and Molecular Endocrinology
Carol S. Kennedy Professor of Nutrition
Department of Human Nutrition
The Ohio State University
Columbus, OH, USA
* A Late entry is a
comment that arrived after this month's New Hot Papers were already
online for that publishing month.
|
ESI Special Topics,
November 2003
Citing URL - http://www.esi-topics.com/nhp/2003/november-03-MarthaABelury.html
|
|
|